- Report
- January 2024
- 150 Pages
Global
From €4624EUR$4,850USD£3,951GBP
- Report
- January 2024
- 215 Pages
Global
From €7580EUR$7,950USD£6,476GBP
- Report
- January 2024
- 107 Pages
Global
From €3957EUR$4,150USD£3,381GBP
- Newsletter
- May 2024
Global
From €1010EUR$1,135USD£893GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4719EUR$4,950USD£4,032GBP
- Report
- March 2024
- 192 Pages
Global
From €3217EUR$3,374USD£2,749GBP
€3574EUR$3,749USD£3,054GBP
- Report
- June 2023
- 186 Pages
Global
From €5244EUR$5,500USD£4,480GBP
- Report
- January 2024
- 200 Pages
Global
From €4767EUR$5,000USD£4,073GBP
- Report
- January 2024
- 257 Pages
Global
From €4767EUR$5,000USD£4,073GBP
- Report
- December 2023
- 200 Pages
Global
From €4767EUR$5,000USD£4,073GBP
- Report
- February 2024
- 110 Pages
Global
From €4529EUR$4,750USD£3,869GBP
- Report
- September 2023
- 190 Pages
Global
From €2374EUR$2,490USD£2,028GBP
- Report
- November 2023
- 178 Pages
Global
From €4672EUR$4,900USD£3,992GBP
- Report
- January 2024
- 200 Pages
Global
From €3957EUR$4,150USD£3,381GBP
- Report
- March 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,073GBP
- Report
- May 2023
- 171 Pages
Global
From €2384EUR$2,500USD£2,036GBP
- Newsletter
- May 2024
- 88 Pages
Global
€1257EUR$1,318USD£1,074GBP
- Report
- January 2024
- 168 Pages
Global
€4762EUR$4,995USD£4,069GBP
- Report
- December 2023
- 212 Pages
Global
€4762EUR$4,995USD£4,069GBP
- Report
- January 2024
- 94 Pages
United States
From €5673EUR$5,950USD£4,847GBP
Bladder cancer is a type of cancer that affects the urinary bladder. It is the sixth most common type of cancer in the United States and the fourth most common type of cancer in Europe. Symptoms of bladder cancer include blood in the urine, pain during urination, and frequent urination. Treatment options for bladder cancer include surgery, chemotherapy, radiation therapy, and immunotherapy.
The oncology market for bladder cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new treatments to improve outcomes for patients, such as targeted therapies and immunotherapies. Additionally, research is being conducted to better understand the biology of bladder cancer and to develop new diagnostic tests.
Companies in the bladder cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more